世界のT細胞リンパ腫市場は、2021年に約15億8,889万米ドルと評価され、予測期間2022-2029年には8.25％以上の健全な成長率で成長すると予想されています。T細胞リンパ腫は、T細胞という免疫系で発生する血液がんの一種です。T細胞リンパ腫市場は、リンパ腫がんの発生率の上昇、T細胞リンパ腫に特異的な治療法の進歩、自己免疫疾患によるリンパ腫のリスクなどの要因により拡大しています。この市場は、Johnson & Johnson（Janssen Pharmaceuticals Inc.）社、Novartis AG社、Bristol Myers Squibb Company社、Merck & Co. Inc.社、および F. Hoffmann-La Roche Ltd.社 によって支配されています。
血液がんの増加により、T細胞リンパ腫の有病率が高まっています。Leukemia & Lymphoma Society®（LLS）の発表によると、アメリカでは約3人に1人が白血病、リンパ腫、骨髄腫のいずれかと診断されています。2021年には、アメリカで合計186,400人が白血病、リンパ腫、骨髄腫と診断されると予想されています。2021年にアメリカで新たに診断されるがん患者数1,898,160人のうち、白血病、リンパ腫、骨髄腫の新規患者数は9.8％を占めると予測されます。さらに、プレミアム価格帯の製品や免疫チェックポイント阻害薬の取り込み、市販製品のラベル拡張に伴う複数の新規治療薬の発売により、今後数年間はこの市場の機会が増加すると予想されます。しかし、治療費の高さと治療薬の有害な副作用が、2022年から2029年の予測期間を通じて市場の成長を阻害しています。
T細胞リンパ腫の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、ブランド製品の優位性と地域の病気の有病率の増加により、収益の面で市場を支配しました。Globocan 2020 レポートによると、2020 年にカナダで 8,506 例の非ホジキンリンパ腫が発生し、313 人が死亡しました。これにより、国内での T 細胞リンパ腫の発生率が増加すると予想されます。アジア太平洋地域は、病気の増加、免疫システムの弱体化、ネチズンの間での健康意識の高まり、政府や非営利団体の市場空間への積極的な参加などの要因により、予測期間中に最高の CAGR で成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. T-Cell Lymphoma Market, by Region, 2019-2029 (USD Million)
1.2.2. T-Cell Lymphoma Market, by Lymphoma Type, 2019-2029 (USD Million)
1.2.3. T-Cell Lymphoma Market, by Therapy Type, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global T-Cell Lymphoma Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global T-Cell Lymphoma Market Dynamics
3.1. T-Cell Lymphoma Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rise in Lymphoma Cancer Incidence
3.1.1.2. Advancements in T-cell Lymphoma-specific Therapies
3.1.1.3. Risk of Lymphoma due to Autoimmune Disorders
3.1.2. Market Challenges
3.1.2.1. High Cost of Treatment
3.1.2.2. Adverse Side Effects of Therapies
3.1.3. Market Opportunities
3.1.3.1. Uptake Of Premium-Priced Products and Immune Checkpoint Inhibitors
3.1.3.2. Launch Of Several Novel Therapies with Label Extension of Commercialized Products
Chapter 4. Global T-Cell Lymphoma Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global T-Cell Lymphoma Market, by Lymphoma Type
6.1. Market Snapshot
6.2. Global T-Cell Lymphoma Market by Lymphoma Type, Performance - Potential Analysis
6.3. Global T-Cell Lymphoma Market Estimates & Forecasts by Lymphoma Type 2019-2029 (USD Million)
6.4. T-Cell Lymphoma Market, Sub Segment Analysis
6.4.1. Peripheral T-cell Lymphoma
6.4.2. T-cell Lymphoblastic Lymphoma
Chapter 7. Global T-Cell Lymphoma Market, by Therapy Type
7.1. Market Snapshot
7.2. Global T-Cell Lymphoma Market by Therapy Type, Performance - Potential Analysis
7.3. Global T-Cell Lymphoma Market Estimates & Forecasts by Therapy Type 2019-2029 (USD Million)
7.4. T-Cell Lymphoma Market, Sub Segment Analysis
7.4.1. Radiotherapy
7.4.2. Chemotherapy
7.4.3. Immunotherapy
7.4.4. Stem Cell Transplantation
7.4.5. Other Types of Therapies
Chapter 8. Global T-Cell Lymphoma Market, Regional Analysis
8.1. T-Cell Lymphoma Market, Regional Market Snapshot
8.2. North America T-Cell Lymphoma Market
8.2.1. U.S. T-Cell Lymphoma Market
8.2.1.1. Lymphoma Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Therapy Type breakdown estimates & forecasts, 2019-2029
8.2.2. Canada T-Cell Lymphoma Market
8.3. Europe T-Cell Lymphoma Market Snapshot
8.3.1. U.K. T-Cell Lymphoma Market
8.3.2. Germany T-Cell Lymphoma Market
8.3.3. France T-Cell Lymphoma Market
8.3.4. Spain T-Cell Lymphoma Market
8.3.5. Italy T-Cell Lymphoma Market
8.3.6. Rest of Europe T-Cell Lymphoma Market
8.4. Asia-Pacific T-Cell Lymphoma Market Snapshot
8.4.1. China T-Cell Lymphoma Market
8.4.2. India T-Cell Lymphoma Market
8.4.3. Japan T-Cell Lymphoma Market
8.4.4. Australia T-Cell Lymphoma Market
8.4.5. South Korea T-Cell Lymphoma Market
8.4.6. Rest of Asia Pacific T-Cell Lymphoma Market
8.5. Latin America T-Cell Lymphoma Market Snapshot
8.5.1. Brazil T-Cell Lymphoma Market
8.5.2. Mexico T-Cell Lymphoma Market
8.5.3. Rest of Latin America T-Cell Lymphoma Market
8.6. Rest of The World T-Cell Lymphoma Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Genmab AS
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Johnson & Johnson (Janssen Pharmaceuticals Inc.)
9.2.3. Mundipharma International, Limited
9.2.4. Bristol-Myers Squibb Company
9.2.5. Autolus Therapeutics PLC
9.2.6. Acrotech Biopharma, Inc.
9.2.7. Macopharma
9.2.8. Merck & Co. Inc.
9.2.9. F. Hoffmann-La Roche Ltd
9.2.10. Novartis AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global T-Cell Lymphoma Market, report scope
TABLE 2. Global T-Cell Lymphoma Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global T-Cell Lymphoma Market estimates & forecasts by Lymphoma Type 2019-2029 (USD Million)
TABLE 4. Global T-Cell Lymphoma Market estimates & forecasts by Therapy Type 2019-2029 (USD Million)
TABLE 5. Global T-Cell Lymphoma Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 6. Global T-Cell Lymphoma Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global T-Cell Lymphoma Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global T-Cell Lymphoma Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global T-Cell Lymphoma Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global T-Cell Lymphoma Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global T-Cell Lymphoma Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global T-Cell Lymphoma Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global T-Cell Lymphoma Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global T-Cell Lymphoma Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. U.S. T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 17. U.S. T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. Canada T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 19. Canada T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 20. Canada T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. UK T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 22. UK T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 23. UK T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. Germany T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 25. Germany T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 26. Germany T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. France T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 28. France T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 29. France T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. Italy T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 31. Italy T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 32. Italy T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Spain T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 34. Spain T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 35. Spain T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. RoE T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 37. RoE T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 38. RoE T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. China T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 40. China T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 41. China T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. India T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 43. India T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 44. India T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. Japan T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 46. Japan T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 47. Japan T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. South Korea T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 49. South Korea T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 50. South Korea T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. Australia T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 52. Australia T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 53. Australia T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. RoAPAC T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 55. RoAPAC T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 56. RoAPAC T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. Brazil T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 58. Brazil T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 59. Brazil T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Mexico T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 61. Mexico T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 62. Mexico T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. RoLA T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 64. RoLA T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 65. RoLA T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. Row T-Cell Lymphoma Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 67. Row T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 68. Row T-Cell Lymphoma Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. List of secondary sources, used in the study of global T-Cell Lymphoma Market
TABLE 70. List of primary sources, used in the study of global T-Cell Lymphoma Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global T-Cell Lymphoma Market, research methodology
FIG 2. Global T-Cell Lymphoma Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global T-Cell Lymphoma Market, key trends 2021
FIG 5. Global T-Cell Lymphoma Market, growth prospects 2022-2029
FIG 6. Global T-Cell Lymphoma Market, porters 5 force model
FIG 7. Global T-Cell Lymphoma Market, pest analysis
FIG 8. Global T-Cell Lymphoma Market, value chain analysis
FIG 9. Global T-Cell Lymphoma Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global T-Cell Lymphoma Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global T-Cell Lymphoma Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global T-Cell Lymphoma Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global T-Cell Lymphoma Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global T-Cell Lymphoma Market, regional snapshot 2019 & 2029
FIG 15. North America T-Cell Lymphoma Market 2019 & 2029 (USD Million)
FIG 16. Europe T-Cell Lymphoma Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific T-Cell Lymphoma Market 2019 & 2029 (USD Million)
FIG 18. Latin America T-Cell Lymphoma Market 2019 & 2029 (USD Million)
FIG 19. Global T-Cell Lymphoma Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
